-
101
THE GENUS AS, A POTENTIAL SOURCE OF ANTICANCER AGENT: AN UPDATED REVIEW
Published 2024-02-01“…However, the adverse side effects of chemotherapy have prompted researchers to investigate whether medicinal plants could replace chemotherapy in cancer treatment. …”
Get full text
Article -
102
A REVIEW OF THE MODERN TRENDS IN THE SURGICAL TREATMENT OF MALIGNANT BONE TUMORS IN CHILDHOOD
Published 2023-09-01“…Current treatment of both entities is multidisciplinary and consists of preoperative chemotherapy (sometimes in combination with radiation therapy), surgery to remove the tumor, and postoperative chemotherapy. …”
Get full text
Article -
103
Rechallenge therapy versus tyrosine kinase inhibitor (TKI) for advanced metastatic colorectal cancer: a retrospective study
Published 2025-02-01“…This study aims to evaluate the efficacy and survival outcomes of tyrosine kinase inhibitor (TKI) versus chemotherapy rechallenge in third-line treatment for advanced mCRC patients. …”
Get full text
Article -
104
Exploring and detecting predictors associated with survival and mortality of cervical cancer patients: a 10-year retrospective study
Published 2025-02-01“…Using cox regression analysis, advanced age (age > 50 years: hazard ratio (HR): 1.82), underweight (BMI < 18.5: HR:1), postmenopause (HR:1), advanced stage of cervical cancer (Stage I, Stage II, Stage III, Stage IV: HR:1, HR:2.78, HR:10.08, HR:20.81), poorly differentiated cervical cancer (HR:1.70), radiation therapy (HR:4.86), chemotherapy (HR:6.55) or chemoradiation therapy (HR:3.31) and surgery plus chemotherapy (HR: 4.55) were identified to be significant predictors of mortality among cervical cancer patients. …”
Get full text
Article -
105
A remarkable and durable response to tislelizumab treatment of an anaplastic thyroid carcinoma without targetable genomic alterations: a case report
Published 2025-02-01“…The patient was unable to tolerate chemotherapy; therefore, radiotherapy was administered initially to prevent airway compression resulting from disease progression. …”
Get full text
Article -
106
EMA/CO Combination Chemotheraphy in Gestational Trophoblastic Neoplasia: Update of Our Results
Published 2015-08-01“… OBJECTIVE: In this study, we aimed updating our experience about the treatment success of EMA-CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide, vincristine) chemotherapy in high-risk gestational trophoblastic neoplasia (GTN). …”
Get full text
Article -
107
The Impact of Chronic Pelvic Pain and Bowel Morbidity on Quality of Life in Cervical Cancer Patients Treated With Radio (Chemo) Therapy. A Systematic Literature Review
Published 2025-02-01“…Studies reported disruptions in nearly all domains of quality-of-life, including global, physical, emotional/psychological, financial, sexual, social, role functioning as a result of being treated with radiotherapy or radio-chemotherapy.Conclusion: Chronic pelvic pain and bowel morbidity are common adverse events experienced by cervical cancer patients receiving, or who have received, pelvic radiotherapy or radio-chemotherapy. …”
Get full text
Article -
108
Pharmacogenetic markers of colorectal cancer treatment. New approaches for cytostatic drugs efficacy estimation
Published 2015-12-01“…The success of CRC chemotherapy depends significantly on the individual genetic features of the patient influencing both efficacy of pharmacological effects, and degree of side effects severity. …”
Get full text
Article -
109
Case of Solid Pseudopapillary Neoplasm of Pancreas
Published 2025-02-01“…However, the patient subsequently developed metastasis to the liver and lungs, prompting the initiation of systemic chemotherapy. The patient died seven months after the development of metastasis and 39 months following the primary diagnosis. …”
Get full text
Article -
110
Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis
Published 2025-02-01“…Targeting CERT sensitizes solid cancer cells to chemotherapy. However, whether targeting CERT to induce ceramide accumulation thereby improving AML therapy efficiency remains elusive. …”
Get full text
Article -
111
Triple Local Recurrence of Synovial Sarcoma: A Case Report
Published 2023-10-01“…Two years after the third surgery and adjuvant chemotherapy, the patient had no complaint about a lump and planned a radiograph evaluation. …”
Get full text
Article -
112
FNDC5/irisin mitigates the cardiotoxic impacts of cancer chemotherapeutics by modulating ROS-dependent and -independent mechanisms
Published 2025-03-01“…Cardiotoxicity remains a major limiting factor in the clinical implementation of anthracycline chemotherapy. Though the etiology of doxorubicin-dependent heart damage has yet to be fully elucidated, the ability of doxorubicin to damage DNA and trigger oxidative stress have been heavily implicated in the pathogenesis of chemotherapy-associated cardiomyopathy. …”
Get full text
Article -
113
Self-Perceived Barriers to Pediatric Cancer Care in Sub-Saharan Africa: A Cross-Sectional Multinational Study
Published 2025-02-01“…A questionnaire was administered asking families about self-perceived barriers accessing surgery, radiotherapy, and chemotherapy. To assess associated factors, we conducted a multivariable regression analysis presenting the results as odds ratios (ORs).RESULTSA total of 224 patients with CC was included. …”
Get full text
Article -
114
Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch)
Published 2025-02-01“…Abstract Background This study investigates the long-term cardiac effects of trastuzumab-based chemotherapy in early breast cancer (EBC) survivors. …”
Get full text
Article -
115
Isolated central nervous system relapse in blast crisis of chronic myeloid leukemia: a case report
Published 2025-01-01“…A 46-year-old female with underlying CML in lymphoid blast crisis, previously treated with chemotherapy and tyrosine kinase inhibitors, presented with visual disturbances. …”
Get full text
Article -
116
Dramatic response of advanced pulmonary sarcomatoid carcinoma to tislelizumab combined with anlotinib: a case report
Published 2025-02-01“…Pulmonary sarcomatoid carcinoma (PSC) is a scarce pathologic type of lung cancer of non-small cell lung cancer (NSCLC) that exhibits resistance to conventional chemotherapy and radiotherapy, resulting in a poor prognosis. …”
Get full text
Article -
117
Does stapled colorectal anastomosis in anterior resection always guarantee restoration of intestinal continuity?
Published 2012-07-01“…When sphincter-sparing operations are performed for all stages of rectal cancer the most essential risk factors of non-closure of stoma were progression of disease and chemotherapy treatment and patient death related to it, and patient’s death.…”
Get full text
Article -
118
Gastrointestinal side effects in hepatocellular carcinoma patients receiving transarterial chemoembolization: a meta-analysis of 81 studies and 9495 patients
Published 2025-02-01“…Background: Transarterial chemoembolization (TACE) is a widely used treatment for hepatocellular carcinoma (HCC), combining targeted chemotherapy and embolization. While effective, TACE can be associated with significant gastrointestinal (GI) side effects, impacting a patient’s quality of life. …”
Get full text
Article -
119
Klinefelter syndrome diagnosed at autopsy and small-cell lung carcinoma
Published 2025-01-01“…He was diagnosed with small-cell lung carcinoma. Chemotherapy was administered, but the disease progressed, eventually leading to death. …”
Get full text
Article -
120
Breast Cancer: Coping with Hair Loss
Published 2012-01-01“…There are so many things to pay attention to when faced with cancer and chemotherapy that many women may not take the time to look at the bright side of losing their hair. …”
Get full text
Article